Helsinn ANAM-17-21:Non-Small Cell Lung Cancer and weight loss - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
-Have advanced NSCLC
-Are experiencing weight loss and/or appetite problems
What is Involved?
If you choose to join this study, you will:
-Be in this study for up to 27 weeks
-Be randomized (like the flip of a coin) to get the study drug (Anamorelin HC1) or a placebo (harmless medicine)
-Give blood samples
-Complete regular care and visits